287 related articles for article (PubMed ID: 21204585)
1. Simultaneous delivery of siRNA and paclitaxel via a "two-in-one" micelleplex promotes synergistic tumor suppression.
Sun TM; Du JZ; Yao YD; Mao CQ; Dou S; Huang SY; Zhang PZ; Leong KW; Song EW; Wang J
ACS Nano; 2011 Feb; 5(2):1483-94. PubMed ID: 21204585
[TBL] [Abstract][Full Text] [Related]
2. A biodegradable amphiphilic and cationic triblock copolymer for the delivery of siRNA targeting the acid ceramidase gene for cancer therapy.
Mao CQ; Du JZ; Sun TM; Yao YD; Zhang PZ; Song EW; Wang J
Biomaterials; 2011 Apr; 32(11):3124-33. PubMed ID: 21277018
[TBL] [Abstract][Full Text] [Related]
3. Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapy.
Yang XZ; Dou S; Sun TM; Mao CQ; Wang HX; Wang J
J Control Release; 2011 Dec; 156(2):203-11. PubMed ID: 21839126
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase 2-responsive micelle for siRNA delivery.
Wang HX; Yang XZ; Sun CY; Mao CQ; Zhu YH; Wang J
Biomaterials; 2014 Aug; 35(26):7622-34. PubMed ID: 24929619
[TBL] [Abstract][Full Text] [Related]
5. Co-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA-PCL-PDMAEMA triblock copolymers.
Zhu C; Jung S; Luo S; Meng F; Zhu X; Park TG; Zhong Z
Biomaterials; 2010 Mar; 31(8):2408-16. PubMed ID: 19963269
[TBL] [Abstract][Full Text] [Related]
6. The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells.
Cao N; Cheng D; Zou S; Ai H; Gao J; Shuai X
Biomaterials; 2011 Mar; 32(8):2222-32. PubMed ID: 21186059
[TBL] [Abstract][Full Text] [Related]
7. Polypeptide cationic micelles mediated co-delivery of docetaxel and siRNA for synergistic tumor therapy.
Zheng C; Zheng M; Gong P; Deng J; Yi H; Zhang P; Zhang Y; Liu P; Ma Y; Cai L
Biomaterials; 2013 Apr; 34(13):3431-8. PubMed ID: 23375952
[TBL] [Abstract][Full Text] [Related]
8. Self-assembled biodegradable micellar nanoparticles of amphiphilic and cationic block copolymer for siRNA delivery.
Sun TM; Du JZ; Yan LF; Mao HQ; Wang J
Biomaterials; 2008 Nov; 29(32):4348-55. PubMed ID: 18715636
[TBL] [Abstract][Full Text] [Related]
9. Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug.
Beh CW; Seow WY; Wang Y; Zhang Y; Ong ZY; Ee PL; Yang YY
Biomacromolecules; 2009 Jan; 10(1):41-8. PubMed ID: 19072631
[TBL] [Abstract][Full Text] [Related]
10. Self-assembled star-shaped chlorin-core poly(epsilon-caprolactone)-poly(ethylene glycol) diblock copolymer micelles for dual chemo-photodynamic therapies.
Peng CL; Shieh MJ; Tsai MH; Chang CC; Lai PS
Biomaterials; 2008 Sep; 29(26):3599-608. PubMed ID: 18572240
[TBL] [Abstract][Full Text] [Related]
11. Traceable multifunctional micellar nanocarriers for cancer-targeted co-delivery of MDR-1 siRNA and doxorubicin.
Xiong XB; Lavasanifar A
ACS Nano; 2011 Jun; 5(6):5202-13. PubMed ID: 21627074
[TBL] [Abstract][Full Text] [Related]
12. Amphiphilic methoxy poly(ethylene glycol)-b-poly(ε-caprolactone)-b-poly(2-dimethylaminoethyl methacrylate) cationic copolymer nanoparticles as a vector for gene and drug delivery.
Yue X; Qiao Y; Qiao N; Guo S; Xing J; Deng L; Xu J; Dong A
Biomacromolecules; 2010 Sep; 11(9):2306-12. PubMed ID: 20666510
[TBL] [Abstract][Full Text] [Related]
13. Small interfering RNA-mediated Polo-like kinase 1 depletion preferentially reduces the survival of p53-defective, oncogenic transformed cells and inhibits tumor growth in animals.
Guan R; Tapang P; Leverson JD; Albert D; Giranda VL; Luo Y
Cancer Res; 2005 Apr; 65(7):2698-704. PubMed ID: 15805268
[TBL] [Abstract][Full Text] [Related]
14. Synergistic anticancer effects achieved by co-delivery of TRAIL and paclitaxel using cationic polymeric micelles.
Lee AL; Wang Y; Pervaiz S; Fan W; Yang YY
Macromol Biosci; 2011 Feb; 11(2):296-307. PubMed ID: 21154473
[TBL] [Abstract][Full Text] [Related]
15. Active and passive tumor targeting of a novel poorly soluble cyclin dependent kinase inhibitor, JNJ-7706621.
Danhier F; Ucakar B; Magotteaux N; Brewster ME; Préat V
Int J Pharm; 2010 Jun; 392(1-2):20-8. PubMed ID: 20226846
[TBL] [Abstract][Full Text] [Related]
16. Combination of paclitaxel- and retinoic acid-incorporated nanoparticles for the treatment of CT-26 colon carcinoma.
Hong GY; Jeong YI; Lee SJ; Lee E; Oh JS; Lee HC
Arch Pharm Res; 2011 Mar; 34(3):407-17. PubMed ID: 21547672
[TBL] [Abstract][Full Text] [Related]
17. Dual sensitive and temporally controlled camptothecin prodrug liposomes codelivery of siRNA for high efficiency tumor therapy.
Li Y; Liu R; Yang J; Ma G; Zhang Z; Zhang X
Biomaterials; 2014 Dec; 35(36):9731-45. PubMed ID: 25189519
[TBL] [Abstract][Full Text] [Related]
18. N-acetylgalactosamine functionalized mixed micellar nanoparticles for targeted delivery of siRNA to liver.
Wang HX; Xiong MH; Wang YC; Zhu J; Wang J
J Control Release; 2013 Mar; 166(2):106-14. PubMed ID: 23266452
[TBL] [Abstract][Full Text] [Related]
19. Single-step assembly of cationic lipid-polymer hybrid nanoparticles for systemic delivery of siRNA.
Yang XZ; Dou S; Wang YC; Long HY; Xiong MH; Mao CQ; Yao YD; Wang J
ACS Nano; 2012 Jun; 6(6):4955-65. PubMed ID: 22646867
[TBL] [Abstract][Full Text] [Related]
20. Impact of anti-PLK1 siRNA-containing F3-targeted liposomes on the viability of both cancer and endothelial cells.
Gomes-da-Silva LC; Ramalho JS; Pedroso de Lima MC; Simões S; Moreira JN
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):356-64. PubMed ID: 23659854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]